Rogers Maureen
Department of Dermatology, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
Australas J Dermatol. 2005 Aug;46(3):127-41; quiz 142. doi: 10.1111/j.1440-0960.2005.00165.x.
The term 'erythrokeratodermas' or 'erythrokeratodermias' has been applied to a group of inherited disorders characterized by well-demarcated erythematous lesions and hyperkeratotic plaques. Connexin mutations have been demonstrated to be responsible for most cases of erythrokeratoderma variabilis but there remain some cases without demonstrated connexin mutations, suggesting genetic heterogeneity. The position of progressive symmetric erythrokeratoderma has become rather unclear. Loricin mutations have been found in some cases that clinically resemble variant Vohwinkel syndrome and other cases have features that overlap with those of erythrokeratoderma variablis. Whether progressive symmetric erythrokeratoderma exists as a distinct entity is under question.
术语“红皮角化病”或“红皮角化症”已被用于描述一组遗传性疾病,其特征为边界清晰的红斑性病变和角化过度斑块。已证明连接蛋白突变是大多数变异性红皮角化病病例的病因,但仍有一些病例未发现连接蛋白突变,这表明存在基因异质性。进行性对称性红皮角化病的定位尚不清楚。在一些临床症状类似变异型Vohwinkel综合征的病例中发现了loricin突变,而其他病例则具有与变异性红皮角化病重叠的特征。进行性对称性红皮角化病是否作为一种独立的疾病存在仍存在疑问。